ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Celldex Therapeutics
The Associate Director CMC Drug Substance leads cross‑functional efforts to support GMP external clinical and commercial manufacturing of drug substance, technology transfer, process validation, and regulatory documentation. This role collaborates with internal teams and CDMOs to ensure successful manufacturing, investigations, and continuous process verification for pipeline biologics.
Celldex Therapeutics is a clinical-stage biopharmaceutical company pioneering immunology-based therapies to treat severe inflammatory, allergic, and autoimmune diseases. Their lead program, barzolvolimab, is a humanized monoclonal antibody inhibitor of KIT designed to target mast cells as a core driver of disease. The company leverages deep expertise in antibody-based immunotherapies and proprietary technologies to discover and develop innovative treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Celldex Therapeutics.
8% below the average for this role
Director
Eli Lilly and Company
Associate Director, Technical Operations, Biologics Drug Substance Manufacturing
Travere Therapeutics
Associate Scientific Fellow, Upstream Technology Transfer Lead, Drug Substance Operations, Biotherapeutics Process Development, Pharmaceutical Sciences
BioLife Plasma Services
Principal Scientist/Director, Biologics Drug Substance Commercialization
MSD
Director / Principal Scientist, Biologics Drug Substance Commercialization (BDSC)
MSD
Director, CMC Drug Substance
Olema Oncology